|
Post by careful2invest on Oct 20, 2016 16:14:31 GMT -5
Stop with the fantasy land dreaming mnholdem. You always make more out of things then they are. The volume is nothing for a move like this given the price. This is 100% a squeeze. Sorry to disappoint, but I'm not a member of the "There's No Good News / Nothing is Happening" Club and I never have been. Now that I think of it I forgot to include a possible arbitration ruling, which the judges must have completed within 8 months, but typically it takes less time. If arbitration began in April, we would be getting close to a judgement on settlement related to the Sanofi L&C Agreement. I don't that's it, though. Putting it all into perspective, my friend, a $0.14 jump in pps is a yawner for me. I expect will seem like it for lots of other investors during the coming months. Good fortune to all. I'll take a green end of day, even if it is only a measly .14 cents. I am down so much that the pennies make little to no difference, but an upward pattern beats the hell out of the downward trajectory that has continually beaten us to death (or damn close) May good news follow and make Al's dream become a reality! GLTA TRUE LONGS!
|
|
|
Post by careful2invest on Oct 19, 2016 18:41:05 GMT -5
I'm to busy to be sad! There are people working to get things done. Presentations being planned. Other projects on the way. Will be posted about shortly:-) I love your limitless optimism. Ultimately that is what it will take for Afrezza to succeed in the face of so many challenges. I will stand along side you and all of the optimists until this succeeds. I am not going anywhere either! Sink or swim...I still believe that ultimately, AFREZZA will prevail! I think that MNKD needs to build upon this little bit of exposure on FOX and initiate more features similar to it and run with it! The silence is killing us and more importantly, the pps! GLTA LONGS!
|
|
|
Post by careful2invest on Oct 19, 2016 13:56:21 GMT -5
While it's great to finally see something about AFREZZA in the media, and while the patient is very positive, it always seems like the medical community, (in this case, the doc in this segment) appears to put negativity into the positive air about AFREZZA. In addition, It would have been great to segway into a story about the head of the JDRF using AFREZZA himself and he too is calling AFREZZA life changing as well.
Maybe asking too much, but we long investors have waited years to see anything like this on television. THANK YOU!! This should finally, at minimum, spark conversation about AFREZZA. Hopefully more coverage to follow where someone can explain the benefits in more detail, (Mike C or head of JDRF contact FOX for a follow up) and clarify any misconceptions about efficacy, price, etc...It's definitely a start! About time people. Lets build on this Mike C! GLTA MNKD LONGS!!
|
|
|
Post by careful2invest on Oct 4, 2016 0:35:17 GMT -5
A commercial for AFREZZA? What a novel idea...
When Sanofi partnered with MNKD, and there were no commercials, everyone was coming up with various scenarios on several message boards, basically guessing as to why. Because the silence did not add up! Yet no one had ever even heard of AFREZZA.
Speculation went on and on, excuses were made by many trying to rationalize just why there were no advertisements for this revolutionary treatment of Diabetes. Reluctantly, I too, would accept the reasons (excuses) as to why there were no ads. "It was not time" or one thing or another had to happen first, and then the advertising would begin. And it never happened. Then finally, we realized that Sanofi was sandbagging.
But it was often said or at least thought that once MNKD gets the rights to AFREZZA back, they can certainly promote it like it should have been promoted all along! And we longs could hardly wait...right?
And here we are again! Or should I say still... Even now, very few people have even heard of AFREZZA! Granted, Mike C has done a lot in a relatively short time and I realize that word is getting out, but ever so slowly!
The reason for my post is that it all seems too familiar... The speculation and the "reasons" that there are no commercials, and very few ads at all is sounding very similar as when Sanofi held the reigns. Again, It does not seem to add up!
Are we just not privy to what is actually going on behind the scenes? Otherwise it does not make sense to not have an all out promotion of this ground breaking, revolutionary treatment of Diabetes. At least to get people to talk about it, or to have at the very minimum, have heard the name AFREZZA.
It just seems that we should be much further along with marketing and exposure of AFREZZA, given its revolutionary potential. Frustrating! Yes! That said, I'm still not selling! GLTA TRUE LONGS!
|
|
|
Post by careful2invest on Sept 30, 2016 15:49:35 GMT -5
Surplus wrote... "A presence at some walkathons are just not going to cut it. Just like the vagueness about cash there is vagueness about the DTP efforts from management. Welcome to MNKD ! And the new "transparency" of MNKD 2.0 launch! Not much transparency from what I can tell. I hope that the rumors about Googles interest in MNKD prove to be true, as well as the supposed wonderful news to be announced in October. We could certainly use something positive to stop the bleeding!
FTR, I am a long time long and am not selling any of my position. GLTA TRUE LONGS!
|
|
|
Post by careful2invest on Sept 29, 2016 7:50:53 GMT -5
Medallion Therapeutics, Inc., another AMF company founded by Alfred E Mann, recently completed trials of "an innovative infusion pump which will provide totally accurate delivery of prescribed drugs to people suffering from chronic illnesses such as diabetes and neurodegenerative diseases."
"According to a spokesperson from Medallion Therapeutics the development of the infusion pump by the team at AMF comes after more than 10 years of research and development to create the novel Medallion implantable drug delivery system.
"Announcing the formation of Medallion Therapeutics David Hankin, Chief Executive Officer of the Alfred Mann Foundation, remarked that the new infusion pump holds considerable promise of providing patients and physicians with a superior method of infusion therapy than what is currently available on the market
I do find that interesting! I also found it interesting that the "artificial pancreas" gets a relatively fast approval by he FDA, and while watching ABC news this morning, they announce the pump, show photos of it, etc. The very next day after approval, major media exposure!
The contrast of the path that AFREZZA has had to take has been very different, to say the least. Just an observation... GLTA TRUE LONGS!
|
|
|
Post by careful2invest on Sept 20, 2016 22:59:26 GMT -5
It's amazing how many people here are still so positive. We are in deep poo poo. Scripts should be a little higher at this point. Just read Seeking Alphas new hit piece MannKind: My Public Response To MannKind's Chief Commercial Officer. Even if this guy is half right we are so screwed. The writing is on the wall and there is no time left. Just waiting for the fat lady to sing... Oh and by the way I'm not a basher I have over 14000 shares. God I feel like crying. "Even if this guy is half right, we are so screwed" Good thing is, he is not right! Mike Castagna's response to a different bashing article recently written by Spencer exposes his deceitful MO. if you have not read it, it is worth checking out. Granted, MNKD is nowhere near where I thought that we would be by now and I invested in this stock over 7 years ago! But I still think that we will get there! Spencer is using every opportunity to kick MNKD and AFREZZA while they are down. No secret there! Spencer is always consistent in creating titles of gloom and doom on every article that he writes about MNKD. (and he has written many) The time alone dedicated to just making charts and graphs is over the top. Yet he claims that he only does it because he likes making charts, predictions and the like! Really?? I don't buy it! That is an excessive amount of time for an individual to dedicate to a supposed worthless, going nowhere little biotech that is trading below .70 cents/ share. Don't you think? It just does not add up! He also screens the responses that are sent to him and does not post responses from readers that call him out on his bogus claims, that would expose him, even when using credible, documented facts and without any rudeness involved. It has happened to me! I no longer engage in dialogue with him. I did write a comment in his latest article that you mentioned letting him know how "great" he is! Ha ha Thats what he wants to hear! GLTA TRUE LONGS!
|
|
|
Post by careful2invest on Aug 29, 2016 5:34:47 GMT -5
yes, and MNKD has no obligation to report the rx to public. well, that move gonna hurt the sp badly. Most of us thought that if the rx is good, they surely want to reveal it. If it's bad, the best way is to hide it. Unless I am misinterpreting something, I think that Mike C's tweet is just saying that in the future, weekly prescription numbers will come directly from MNKD. Not to hide anything whatsoever. I believe it is in an effort to have them posted at a set time instead of being at the mercy of others to get script counts. Simple as that. The last two weeks, the report has been delayed. Along with everything else that was jacked up, I believe that he is attempting to correct that too! GLTA LONGS, and PWD!
|
|
|
Post by careful2invest on Aug 22, 2016 16:43:38 GMT -5
Gosh, you people are soooooooooooo bitter toward SNY!! Do you feel differently toward Sanofi? And if so, why?
|
|
|
Post by careful2invest on Aug 5, 2016 12:58:54 GMT -5
careful2invest wrote: "Also, to respond to another comment... IMHO, it would not be a desperate move for MNKD management to dispatch someone to contact Dr. Combs at some level. Maybe not to set up a full fledged conference right away, but a follow up, nonetheless, to keep that interest alive." Hit yourself upside the head, careful2invest, just the opportunity to meet Sports should be more than enough incentive to set up a meeting, if the Doc shows up, all the better!! IF the picture depicted on "sports" posts is really her, you have a very good point babaoriley! That alone should entice any red blooded man on the planet to set up a meeting! And while there, maybe even talk about AFREZZA! We've waited this long...Hopefully the increase in scripts rises in the week, months, years to come! Enjoy the weekend everyone! GLTA MNKD LONGS!
|
|
|
Post by careful2invest on Aug 5, 2016 11:22:18 GMT -5
That is very frustrating! I certainly was not expecting that. While I acknowledge that none of us on this mb know exactly what is going on behind the scenes (with the exception of Mike C) but Dr. Combs displayed enthusiasm around AFREZZA and to not tap that resource and the chain reaction of physician contacts to him that would follow, appears to be a missed opportunity. It makes one wonder how many others are out there that are interested in AFREZZA and are not being followed up with. We cannot afford to do this. I am tired of hearing peoples rationale of another negative event/result. We heard enough excuses while under Sanofi's control. (And even I tried to accept them at that time) But look where we ended up with them. I have owned this stock for almost eight years. A very grueling eight years. As we all know, this is a do or die launch! Every stone needs turned, every lead need a follow up, any opportunity for exposure of what AFREZZA can do for a Diabetic needs the full attention that it deserves! Come on fellas, complete Alfred Manns vision! Make AFREZZA a household name! As it is worthy. No more excuses, Lets see some results! Positive results! GLTA MNKD LONGS! did you write to mannkind either to Matt or Mike? posting here wouldnt get far Mike Castagna is on this message board. Hopefully he browses through it on occassion. I have talked directly to Matt, but it was months ago. In all honesty, none of what I wrote should be news to them! (At least I hope that its not) Also, to respond to another comment... IMHO, it would not be a desperate move for MNKD management to dispatch someone to contact Dr. Combs at some level. Maybe not to set up a full fledged conference right away, but a follow up, nonetheless, to keep that interest alive. Every lead needs a follow up! It is imperative that AFREZZA gets into the hands of those that can prescribe it to those that need it. Like I said before, the chain reaction of this occurence will pay us back tremendously! The snowball effect...It needs to keep growing! It is do or die, for MNKD and for AFREZZA! Not to mention the patients. It needs to be an all out effort! And yes, patience is a virtue, and I am trying to be reasonable, but I will be honest, eight years of this has spent most of my patience. But I still believe in the technology and the promise of AFREZZA and TECHNOSPHERE, and I'm in too deep to bail now anyway! GLT MNKD and to all MNKD LONGS!
|
|
|
Post by careful2invest on Aug 5, 2016 10:01:20 GMT -5
Scripts have dropped from the previous week. We have a group of doctors interested in the drug yet MNKD hasn't reached out yet. That is very frustrating! I certainly was not expecting that. While I acknowledge that none of us on this mb know exactly what is going on behind the scenes (with the exception of Mike C) but Dr. Combs displayed enthusiasm around AFREZZA and to not tap that resource and the chain reaction of physician contacts to him that would follow, appears to be a missed opportunity. It makes one wonder how many others are out there that are interested in AFREZZA and are not being followed up with. We cannot afford to do this. I am tired of hearing peoples rationale of another negative event/result. We heard enough excuses while under Sanofi's control. (And even I tried to accept them at that time) But look where we ended up with them. I have owned this stock for almost eight years. A very grueling eight years. As we all know, this is a do or die launch! Every stone needs turned, every lead need a follow up, any opportunity for exposure of what AFREZZA can do for a Diabetic needs the full attention that it deserves! Come on fellas, complete Alfred Manns vision! Make AFREZZA a household name! As it is worthy. No more excuses, Lets see some results! Positive results! GLTA MNKD LONGS!
|
|
|
Post by careful2invest on Apr 23, 2016 10:11:08 GMT -5
Saturday morning, 4/23/16 While on the Nasdaq website, I looked up MNKD Realtime Quote. It states $7.10/ share. Typo? Projection? Any thoughts or ideas as to why? I know that we will reach this number and frankly, blow way past it, but I do not understand it being noted at that price, at this time. GLTA TRUE LONGS!
|
|
|
Post by careful2invest on Feb 27, 2016 23:44:22 GMT -5
This is the same concept as store within store, Apple, Samsung stores within Thousands of Best Buy stores nationwide. Apple, Samsung paid a lot to do just that. Small player can't afford that. Matt's slide mentioned large scale deployment. Good point. Why haven't they put up a disclaimer if they are an established company? Even if Dexcom is involved in it, why don't they disclose this? No need to hide. I do not think that anyone is hiding... However, I do believe that it is Verily and Dexcom (Vdex) and Sanofi will distribute Afrezza to them. And IMHO, the big reveal will be all at once for greatest impact! Time will tell!
|
|
|
Post by careful2invest on Feb 14, 2016 13:28:32 GMT -5
Press release likely wouldn't be seen by general population and it would create ill-will with the NYT author. Better to stay on good side and try to get future articles with positive comments/news. At least that is what I'd do. Agree. And Matt has stated that it is not possible to refute every rumors and there is no need to. As long as Matt focuses on the big pictures and get those things took care of, we will be fine. I understand Matt's mindset to a degree about not responding to every rumor, however, what was written by the WSJ, a prominent news source to many, was blatently over the top! Maybe Matt could start a rebuttle by stating that there have been many outrageous things written and said about MNKD/Afrezza, etc... and normally we ignore it, but on this I must comment, especially after many of our investors had requested that we do so. Possibly by addressing it in this manor, he wuld put to rest some of the uncertainty that remains among the general public, while also including that MNKD may not comment on other Fud in the future, but don't let that be a sign or imply an image of weakness bc we have total faith in the future of Afrezza being that of great success! Or words to that effect. I do not feel that the silence has served Afrezza nor has it served us investors. JMHO
|
|